Interim data for ACT III: Phase II trial of PF-04948568 (CDX-110) in combination with temozolomide (TMZ) in patients (pts) with glioblastoma (GBM).


Journal Article

Full Text

Duke Authors

Cited Authors

  • Lai, R; Recht, LD; Reardon, DA; Paleologos, N; Groves, MD; Rosenfeld, MR; Meech, S; Davis, TA; Pavlov, D; Sampson, JH

Published Date

  • May 20, 2010

Published In

Volume / Issue

  • 28 / 15_suppl

Start / End Page

  • 2014 - 2014

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2010.28.15_suppl.2014


  • en